This peptide blend combines three complementary compounds commonly used in growth hormone, metabolic, and body composition research models. By targeting multiple regulatory pathways simultaneously, the blend allows researchers to investigate growth hormone release dynamics in a controlled and reproducible laboratory setting.
Tesamorelin is a GHRH analog used in research to stimulate the anterior pituitary and support sustained growth hormone signaling.
CJC-1295 no DAC is a modified GHRH peptide utilized for short-acting, pulsatile growth hormone stimulation in experimental protocols.
Ipamorelin is a selective GHRP frequently studied for its ability to promote growth hormone release with minimal interaction with cortisol and prolactin pathways.
